Replies to post #471920 on NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

I have seen that first hand how neurologists/neurosurgeons come together on important issues including FDA approvals, reimbursements, etc on the medical device side. As long as the data is good and is coupled with excellent safety…,

More discussions amongst the executive circle (on the medical device side) recently is that FDA is taking an even more relaxed approach towards efficacy data as long as the safety profile is fantastic. And this is how RAs around the world will transition in the coming years. Again, all for the patients so they have the ultimate flexibility to choose what they want!